Autoimmune Hemolytic Anemia: Causes, Pathophysiology, Symptoms, Diagnosis, and Treatment


◉ Introduction


◉ Warm Autoimmune Hemolytic Anemia

This occurs when the immune reaction happens at a temperature above 37 degrees Celsius (roughly the normal body temperature). It involves Immunoglobulin G antibodies, which are of limited specificity, and the symptoms generally show over the course of a few weeks.

Hemolysis mainly occurs intravascularly, and rarely in the liver and spleen. It does not occur as a result of direct lysis (destruction) of red blood cells.


◉ Cold Autoimmune Hemolytic Anemia

This type is also referred to as cold agglutinin or antibody disease, and it is the type where the antibodies react at a temperature lower than 37 degrees Celsius, such as when the body is exposed to cold. Usually, it occurs due to an idiopathic cause, or more prominently infections like Mycoplasma pneumoniae or infectious mononucleosis, or less frequently lymphoproliferative disorders.

The antibodies involved in the cold agglutinin type are usually Immunoglobulin M, and the hemolysis occurs in the extravascular system in the liver and spleen.

◉ Symptoms and Signs of Autoimmune Hemolytic Anemia

Symptoms of autoimmune hemolytic anemia slightly vary according to whether it is the warm or the cold type, but they show a wide range of symptoms such as:

Symptoms specific to warm autoimmune hemolytic anemia tend to be as a result of the anemia and are less specific, but cold agglutinin disease may show additional symptoms that are mainly cold-associated but may also include:

◉ Causes of Autoimmune Hemolytic Diseases

The most common cause of the majority of cases of AIHA is idiopathic, meaning the cause is unknown, and there is no underlying chronic disease or infection that might cause a secondary manifestation of this disease. However, these chronic diseases might include:

◉ Diagnosis of Autoimmune Hemolytic Anemia

For proper diagnosis of AIHA, your healthcare provider might request a Complete Blood Count (CBC) to see if anemia is present, which will alert the physician that hemolysis might be the cause of anemia.

Once anemia is diagnosed, mainly through low hemoglobin and red blood cell count, further investigations and tests are required. These might include:

◉ Treatment of Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia treatment is approached through the treatment of the underlying cause at first. So, upon management and treatment of lupus, for example, these symptoms should disappear. If medications such as sulfonamide are the cause, it is best if this medication is discontinued. Sometimes the symptoms are so mild no treatment is required.

The main line of medical treatment is a steroid prescription typically since it is an autoimmune disease, such as hydrocortisone, to reduce the immune system's ability to produce the antibodies that attack and destroy the red blood cells.

If steroids don't work, then immunosuppressants may be prescribed to stop the immune response and spare the bone marrow from being attacked. Sometimes medications don't work or don't produce a satisfactory result. When this happens, your healthcare provider might suggest surgery to remove the spleen (splenectomy). This is because the spleen is responsible for the elimination of abnormal cells floating around in the blood, so less destruction of red blood cells occurs when it is removed. Severe cases of autoimmune hemolytic anemia, warm or cold, may need regular blood transfusion to reduce the symptoms and prolong life expectancy.

◉ Conclusion

Autoimmune hemolytic anemia is a rare disease where the body mistakenly produces antibodies that attack and destroy the red blood cells causing symptoms of anemia and hemolysis. It has two types: cold and warm, classified according the temperature at which the immune reaction occurs. This typically occurs on top an already present chronic illness. Furthermore, it is diagnosed by a positive Coomb’s test and the first line of treatment is steroids.



References

  1. Jäger, U., Barcellini, W., Broome, C., Gertz, M. A., Hill, A., Hill, Q. A., Jilma, B., Kuter, D. J., Michel, M., Montillo, M., Röth, A., Zeerleder, S., & Berentsen, S. (2020). Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Reviews, 41, 100648. https://doi.org/10.1016/j.blre.2019.100648
  2. Autoimmune hemolytic anemia. (2016, October 24). WebMD. https://www.webmd.com/a-to-z-guides/autoimmune-hemolytic-anemia
  3. Park, S. H. (2016). Diagnosis and treatment of autoimmune hemolytic anemia: classic approach and recent advances. Blood Research, 51(2), 69. https://doi.org/10.5045/br.2016.51.2.69
  4. Hill, A., & Hill, Q. A. (2018). Autoimmune hemolytic anemia. Hematology, 2018(1), 382–389. https://doi.org/10.1182/asheducation-2018.1.382
  5. Braunstein, E. M. (2024, February 21). Autoimmune hemolytic anemia. MSD Manual Professional Edition. https://www.msdmanuals.com/professional/hematology-and-oncology/anemias-caused-by-hemolysis/autoimmune-hemolytic-anemia
  6. Professional, C. C. M. (n.d.). Autoimmune hemolytic anemia. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/22349-autoimmune-hemolytic-anemia